---
figid: PMC8869483__biomedicines-10-00261-g002
figtitle: 'Targeting NFKB Signaling in Cancer Stem Cells: A Narrative Review'
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8869483
filename: biomedicines-10-00261-g002.jpg
figlink: /pmc/articles/PMC8869483/figure/biomedicines-10-00261-f002/
number: F2
caption: 'NF-κB signaling involves at least two different pathways: An alternative
  pathway with upstream kinase NIK and a dimer of IKK-1. In this pathway, the precursor
  of p52 acts as an inhibitory subunit. The classical pathway involves a dimer of
  upstream kinases (TAK1, TAB), which could activate a trimeric signalosome composed
  of NEMO (docking component), IKK-1, and IKK-2. Activation of signalosome leads to
  phosphorylation of IκB-α at serine 32 and 36, followed by ubiquitination and subsequent
  degradation within the proteasome. For further details, see the text.'
papertitle: 'Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review.'
reftext: Barbara Kaltschmidt, et al. Biomedicines. 2022 Feb;10(2):261.
year: '2022'
doi: 10.3390/biomedicines10020261
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: cancer stem cells | NF-κB | EGF | PD-L1 | lenalidomide | bortezomib | dexamethasone
automl_pathway: 0.9410018
figid_alias: PMC8869483__F2
figtype: Figure
redirect_from: /figures/PMC8869483__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8869483__biomedicines-10-00261-g002.html
  '@type': Dataset
  description: 'NF-κB signaling involves at least two different pathways: An alternative
    pathway with upstream kinase NIK and a dimer of IKK-1. In this pathway, the precursor
    of p52 acts as an inhibitory subunit. The classical pathway involves a dimer of
    upstream kinases (TAK1, TAB), which could activate a trimeric signalosome composed
    of NEMO (docking component), IKK-1, and IKK-2. Activation of signalosome leads
    to phosphorylation of IκB-α at serine 32 and 36, followed by ubiquitination and
    subsequent degradation within the proteasome. For further details, see the text.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF13C
  - TNFRSF1A
  - IL1R1
  - MAP3K14
  - MAP4K4
  - MAP3K7
  - NR2C2
  - TAB1
  - TAB2
  - TAB3
  - CHUK
  - IKBKG
  - IKBKB
  - RELB
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - FKBP4
  - GTF2H4
  - PMPCB
  - PSIP1
  - H3P42
  - RELA
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - Ni-K
  - msn
  - Tak1
  - Tab2
  - Abd-B
  - nmo
  - Tudor-SN
  - Pep
  - mrn
  - Rel
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - il1rl1
  - chuk
  - ikbkg
  - ikbkb
  - relb
  - nfkb2
  - rela
  - nfkb1
---
